The Sponsor
Loading page...
Mergers & Acquisitions
Private Equity
Corporate
Javier Oliver-Keymorth is a corporate partner at Kirkland & Ellis LLP, based in the Austin office. With a focus on private equity and corporate transactions, Javier represents private equity firms and their portfolio companies in various business aspects. He has extensive experience in mergers and acquisitions, having worked on significant deals such as the $380 million growth investment in SmileDirectClub and the $16 billion purchase of Flipkart by Walmart. Javier holds a JD from Harvard Law School and a BA in Political Science & Psychology from the University of California, Berkeley.
Deal Summary
- FFL Partners acquired the target/assets from Janus RX, LLC in a private equity transaction on not available. - Deal value was 1300000000 Sector: Healthcare; Location: USA. - On the acquirer side, not available advised, led by Rodin Hai-Jew, Javier Oliver-Keymorth, Lauren Iwasaki, Yangxier Sui, Erica Berthou, Paul Watt, Zeke Couch, Indira Selimovic, Zach Scott Roemer, Katie Taylor, Negin Fatahi, Meredith Levy, Heidi Yuen, Zak Morozov, Keaton Bolton, Pamela Ho, Dennis Williams, Brian King, Martin Schwertmann, Eamon Condon, Matt Wood, Dom Collins, Rob Miceli, Ben Stoyenko, Caroline Harrod.
Oct 24 2025
1B
Private Equity
Partner
2023 – Unknown
Associate
2017 – 2021
Of Counsel
2021 – 2023
- Abacus Group merged with Medicus IT in a merger on not available. - Deal value was 4100000000 Sector: Information Technology; Location: USA. - On the acquirer side, counsel was not available; lawyers included Rodin Hai-Jew, Javier Oliver-Keymorth, Lauren Iwasaki, Alexi Warren, Joe Caputo, Katie Taylor, Aaron Shubert, Heidi Yuen, Zak Morozov, Erica Berthou, Zeke Couch, Indira Selimovic.
Jul 15 2025
4B
Private Equity
Kirkland & Ellis advised Marlin Equity Partners and its portfolio company Virgin Pulse, a leading global digital-first health, wellbeing and navigation company, in connection with Virgin Pulse’s definitive agreement to merge with HealthComp, a next generation benefits and analytics platform. The merger will create a technology and data powered health platform-as-a-service organization poised to tackle some of the industry’s biggest challenges. The merger is expected to close in Q4 2023, subject to regulatory approvals and satisfaction of all closing conditions under the definitive agreement. Financial details of the transaction have not been disclosed. Read the transaction press release The Kirkland team was led by corporate partners John Kaercher, Patrick Salvo, Brendan Caldon and Javier Oliver-Keyworth, with support from partner Marc Browning, and associates Brett Mele, Evan Chavez and Braxton Smith; debt finance partners David Nemecek and Paul Rezvani and associate Elena Babakhanyan; and tax partner Kevin Coenen and associate Michael Alcan.
Sep 28
1 min
Associate
2015 – 2017
Summer Associate
2014 – 2014
Law Clerk
2015 – 2015
Legal Intern
2014 – 2014
Law Clerk
2013 – 2013
Policy Fellow
2010 – 2011
